Sacubitril–valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction
Claudio Passino, Paolo Sciarrone, Giuseppe Vergaro, Chiara Borrelli, Jens Spießhoefer, Francesco Gentile, Michele Emdin, Alberto Giannoni
Topics & Concepts
MedicineSacubitrilValsartanEjection fractionSacubitril, ValsartanHeart failureCardiologyInternal medicineCentral sleep apneaCardiorespiratory fitnessApneaPolysomnographyBlood pressureAtrial Fibrillation Management and OutcomesObstructive Sleep Apnea ResearchCardiovascular Function and Risk Factors